Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 11Terminated 2Withdrawn 1Unknown 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 7Neoplasms 3Pain, Postoperative 2Cancer Pain 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Substance Withdrawal Syndrome 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Sodium Bicarbonate 2Morphine 2Fentanyl 2rofecoxib 1naloxegol 1incobotulinumtoxinA 1Oxycodone 1Oxcarbazepine 1Methadone 1Lenalidomide 1Duration of Therapy 1Donepezil 1Cryotherapy 16'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Cancer Pain × Morphine × Clear all
NCT02078089 2017-01-31

Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain

Indiana University

Phase 1 Terminated
1 enrolled

Cancer Pain, Neoplasms

NCT00634010 2016-05-09

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

M.D. Anderson Cancer Center

Phase 3 Terminated
36 enrolled 6 charts

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡